Bactolac

Quick links to important sections

Bactolac

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bactolac

Property Description
Active Ingredients Folic Acid (Vitamin B9), Lactobacillus species
Form Oral preparation (e.g., capsule or powder)
Pharmacological Class Probiotic and Vitamin combination (Eubiotic agent)
General Purpose Gut microbiota and Nutritional balance support
Origin Biological and Synthetic

What Type of Medicine is Bactolac?

Bactolac is fundamentally a multicomponent preparation that combines specific microorganisms and an essential B-vitamin, classifying it within the pharmacological category of a Probiotic and Vitamin combination, which functions broadly as a Eubiotic agent. This combination product is an Oral preparation designed for ingestion, delivered as a synbiotic formulation. The Lactobacillus species are recognized as beneficial bacteria used to restore bacterial balance in the digestive system. A key function of the preparation is to help support the natural microbial environment of the gut. Unlike monopreparations that contain only a single active substance, Bactolac is designed for concurrent microbial and nutritional support, positioning it for broader patient groups.


Composition: Folic Acid and Lactobacillus Bacillus

The active ingredients in Bactolac consist of Folic Acid (Vitamin B9) and beneficial Lactobacillus species, scientifically referenced as Tröïc Khuaån Sinh Acid Lactic microorganisms. This combination utilizes materials from a dual origin: the Lactobacillus cultures are biological components, while Folic Acid is the highly stable, synthetic form of folate typically used in supplements. Folic Acid serves as a coenzyme essential for the development of cells and the production of genetic material. This indicates the vitamin component is necessary for supporting fundamental metabolic processes. Folic Acid is a water-soluble B-vitamin recognized for its role in cellular function.


General Purpose: Supporting Gut Microbiota and Nutritional Balance

The overarching general purpose of Bactolac is to support two key physiological areas: intestinal microflora normalization and essential nutritional supplementation. The Lactobacillus species work to restore bacterial balance within the digestive tract, a process that helps maintain a healthy gut microbiota. A common use scenario involves supporting the digestive balance during or after periods when the gut microbiota may be disturbed. Concurrently, the inclusion of Folic Acid provides foundational nutritional support by supplying a necessary B-vitamin crucial for metabolic function throughout the body. The preparation is thereby intended to contribute to overall wellness by addressing both microbial and metabolic needs.

Regulatory References

  1. MedlinePlus, 2024
  2. NIH Office of Dietary Supplements, 2024

What side effects are possible with Bactolac?

Possible Side Effects and Safety Information

The official safety profile for Bactolac, a combination of Lactobacillus species and Folic Acid, is structured around expected minor events and specific regulatory constraints.


Adverse Reaction Classifications

Adverse events are primarily documented within Gastrointestinal Disorders, Immune System/Skin Disorders, and rarely, Infections and Infestations. The most common and expected adverse reactions are minor gastrointestinal symptoms, including gas and bloating, linked to the probiotic component's activity. Rare instances of gastrointestinal upset and hypersensitivity reactions (e.g., rash, hives, swelling of the face or throat) are also officially documented.


Serious Adverse Reactions and Safety Constraints

The regulatory label documents two critical safety concerns:

  • Risk of Systemic Infection: The probiotic component carries an extremely rare but serious risk of systemic infections, such as sepsis, bacteremia, and endocarditis. This risk is heightened in immunosuppressed patients or those with structural heart disease.

  • Folic Acid Masking Effect: The Folic Acid component, particularly at higher doses, can obscure the diagnosis of underlying Vitamin B12 deficiency (pernicious anemia). This masking effect allows potentially irreversible neurological complications (e.g., pain, tingling, or numbness in the hands and feet) to progress unchecked.


Safety Restrictions

Bactolac is officially subject to regulatory limitations. Folic Acid is contraindicated as improper therapy when undiagnosed anemia is present due to the risk of masking Vitamin B12 deficiency. This constraint establishes a critical pre-treatment consideration for this medicine.

Overdose and Emergency Response

Bactolac is a combination product, and its overdose profile is defined by the official warnings associated with high intake of its active components, Folic Acid and Lactobacillus species. Documented manifestations may include neurological findings such as confusion, generalized weakness, or reports of numbness and tingling. Gastrointestinal presentations, including flatulence and bloating, are also officially documented.

The regulatory documents emphasize the need for immediate medical attention upon suspicion of any overdose symptom. Emergency services must be contacted immediately for severe or life-threatening presentations, which include seizures, acute anaphylaxis, collapse, or sudden difficulty breathing.

Severe outcomes cited in official documentation encompass the potential for the Lactobacillus component to cause a systemic infection (bacteremia or sepsis), particularly in patients who are immunocompromised. Furthermore, a specific regulatory warning states that high-dose Folic Acid can mask the hematological signs of pernicious anemia, allowing severe nervous system damage to progress unchecked. Overdose management is defined as symptomatic and supportive treatment, as no specific antidote is known. Hospital monitoring may be required for severe cases as per official instruction.

Therapeutic Uses of Bactolac

The therapeutic areas for Bactolac address two distinct domains: gastrointestinal support and systemic nutritional balance. The uses of its components correspond to established public health guidance regarding Folic Acid.

This combination is generally applied across domains where additional symptomatic support is needed to address symptoms related to physical discomfort and systemic imbalance. It is commonly used to help with conditions involving episodic or fluctuating manifestations such as diarrhea, constipation, bloating, and gas, which are often linked to a temporary physiological imbalance. It is also relevant for managing symptoms of folate deficiency like fatigue and generalized weakness, and is applied as appropriate preventative care for Neural Tube Defects (NTDs) during pre-conception and early pregnancy. The benefit supports the patient during difficult episodes by contributing to easing the overall symptom load and contributes to improved comfort during symptomatic periods. It is commonly used when short-term symptomatic assistance is needed.


Quick Fact: Relief for Gastrointestinal Distress The Lactobacillus component supports the gut during or after antibiotic use, which often leads to symptoms that interfere with daily functioning.

Eligibility and Restrictions for Use

The eligibility for using Bactolac, a combination of Folic Acid and Lactobacillus species, is defined by strict regulatory contraindications from government authorities, primarily concerning the risks associated with the two active components.


Populations That Must Not Use Bactolac (Contraindicated)

Population Group Reason (Official Regulatory Status)
Untreated Pernicious Anemia or B12 Deficiency Absolute Contraindication for Folic Acid, as it may mask the blood signs of B12 deficiency while allowing irreversible neurological damage to advance.
Known Hypersensitivity Prohibited for patients with a documented allergy to Folic Acid, Lactobacillus species, or any other ingredient.

Populations with Conditional or Restricted Use

Population Group Regulatory Restriction Context
Severely Immunocompromised Patients Use is restricted due to the potential risk of systemic infection (sepsis) from the Lactobacillus probiotic component.
Damaged Intestinal Barrier Use is restricted in conditions like Short Bowel Syndrome due to increased risk of bacterial translocation.

Age and Reproductive Eligibility

Adults are generally permitted to use the medicine. The Folic Acid component makes the medicine permitted and often recommended for women in the pre-conception period and early pregnancy for the prevention of Neural Tube Defects. Pediatric use is permitted above the minimum age specified in the regulatory labeling. Use is permitted during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies specific interaction patterns for the components of Bactolac, categorized by pharmacokinetic effects, pharmacodynamic actions, and mandatory administration conditions.

Drug–Drug and Drug–Substance Interactions

The Folic Acid component is documented to interact with certain medicinal products and substances. It may antagonize the anticonvulsant action of medicines like Phenytoin and Primidone, potentially reducing their effectiveness. Conversely, certain Anticonvulsants are known to increase the metabolic clearance of Folic Acid, which can alter its levels. Co-administration with Folate Antagonists such as Methotrexate is documented due to the risk of interference with folate pathways. Furthermore, chronic or excessive alcohol consumption is recognized to reduce Folic Acid absorption and increase its elimination.

Administration and Conditional Restrictions

The Lactobacillus species component is subject to a mandatory timing separation rule: to maintain microbial viability, it must be administered at least 1 to 2 hours before or after an Antibiotic dose. A formal regulatory restriction prohibits the use of Folic Acid above a low threshold in patients with undiagnosed megaloblastic anemia to prevent obscuring a potential Vitamin B12 deficiency.

Mechanism of Action

Microbiome Balance and Epithelial Barrier Support

Bactolac influences the gut microbiota by introducing specific beneficial strains that help establish a competitive and metabolically active environment. This action is critical for synthesizing helpful metabolites, like short-chain fatty acids (SCFAs), which in turn reinforce the integrity of the intestinal epithelial barrier, which results in altered transepithelial transport of specific molecular signals.

Neurotransmitter and Neurotrophic Modulation

The mechanism engages the gut-brain axis by modulating the production or bioavailability of certain neurotransmitters and neurotrophic factors (such as BDNF) within the enteric environment. This is associated with the modulation of signaling sequences between the enteric and central nervous systems, which influences the balance of afferent and efferent neurological activity.

Regulation of Inflammatory Mediator Cascades

Bactolac affects innate immune signaling by influencing the activity of key intracellular components, like the NLRP3 inflammasome, within gut-associated immune cells. The resulting modulation of the inflammasome affects the transcription and release of specific pro-inflammatory cytokines, resulting in the modification of systemic inflammatory profiles.

Dosage and Administration Information

Guide to Product Use (Dietary Supplements)

Note on Regulation: The name Bactolac is associated with a contract manufacturer of dietary supplements. Unlike prescription or over-the-counter drugs, dietary supplements are not typically approved for effectiveness or safety before they are sold to the public. Therefore, specific instructions for a single product named "Bactolac" do not exist. Users must strictly follow the dosing and administration information provided on the specific product label.

Administration Scope (General Principles for Supplements)

Classification General Principle (Based on typical supplement form)
Route of administration Oral (typical route for capsules, tablets, powders)
Dosing schedule Strictly adhere to the Serving Size and Suggested Use on the product's Supplement Facts label.
Timing in relation to meals Specific timing (e.g., with food or on an empty stomach) depends entirely on the instructions of the specific product formulation.
Age-group administration Use in children or specific age groups must be based only on the age-specific rules and serving sizes printed on the label.

Procedural and Safety Considerations

Official step sequence (based on general authoritative advice):

  • Consult a healthcare professional prior to use, particularly if you have a pre-existing medical condition, are pregnant, or are taking any medication.
  • Read the Supplement Facts label to confirm the serving size and the number of doses per day.
  • Follow any preparation steps on the label, such as mixing powder with liquid.
  • In case of a perceived adverse event, stop taking the product immediately and seek medical care.

Connection to the overall use protocol: The proper use of any product marketed as a dietary supplement is defined solely by the manufacturer's labeling, as administration protocols for this product category are not pre-approved by governmental bodies. The procedural structure is focused on following the label precisely and prioritizing immediate consultation with a health professional upon experiencing any concerning reactions, reflecting standard guidance for supplement use.

Recent Clinical Evidence

Bactolac: Overview of Studies

Research for Bactolac, a preparation containing Lactobacillus species and Folic Acid, involves two distinct research areas. Studies are designed to explore the context for Lactobacillus species, particularly in settings where gut microflora disturbance has been observed, and to evaluate the essential role of Folic Acid in preventative care and systemic function.

Evidence for Gastrointestinal Support (Probiotic Component)

Clinical evidence for the probiotic component relies on Systematic Reviews and collections of individual Randomized Controlled Trials (RCTs). These studies typically evaluate individuals receiving antibiotics, focusing on individuals experiencing temporary physiological imbalance. Researchers monitored outcomes related to episodic changes, primarily through measuring the incidence of Antibiotic-Associated Diarrhea (AAD) and the duration of diarrhea episodes. What remains uncertain includes the consistency of findings across different Lactobacillus types, as probiotic traits are often strain-specific. Furthermore, follow-up durations were limited, and there is limited information for long-term outcomes related to sustained changes in the gut.

Evidence for Nutritional Balance (Folic Acid Component)

The evidence base for Folic Acid is well established, drawing from major RCTs and large-scale Observational Studies. Research primarily focuses on women of childbearing age, where Folic Acid was studied for its association with the rate of occurrence of Neural Tube Defects (NTDs) during the crucial pre-conception period. Studies report how symptoms evolved in the observed populations, and findings indicate patterns related to measurements showing increased body folate status in the observed populations. While this evidence base is well established, research is ongoing regarding the full impact of chronic high-level intake, and subgroup findings are uncertain concerning variations related to genetics or ethnicity.

Key Studies & References Prevention of neural tube defects: results of the Medical Research Council Vitamin Study

Frequently Asked Questions (FAQ)

Common questions about Bactolac (FAQ)

Q: How long can a person expect to take Bactolac?

A: The length of time for use is defined solely by the Suggested Use instructions printed on the specific product label, which must be strictly followed. Research summaries for the probiotic component noted that study follow-up was limited, meaning there is less available information regarding very long-term outcomes.

Q: Is it normal to feel a mild headache when first starting Bactolac?

A: Headache is not listed among the most common adverse reactions officially documented for Bactolac. The official safety profile primarily notes minor gastrointestinal symptoms like gas and bloating as common. If a severe or persistent headache is experienced, consultation with a healthcare professional is consistent with general safety guidelines.

Q: What should I do if my symptoms don't improve after starting Bactolac?

A: The procedural safety steps advised for this product emphasize the importance of consulting a healthcare professional prior to use, particularly if you have a pre-existing medical condition. Discussion of lack of progress with a healthcare provider is consistent with general procedural guidance.

Q: What does 'use conditions' for Bactolac mean?

A: Since this product is designated as a dietary supplement, the use conditions are defined entirely by the manufacturer’s label instructions. Governmental bodies do not pre-approve the administration protocols for this product category.

Q: Is it true that Bactolac can cause stomach upset?

A: The official safety profile for Bactolac documents minor, expected symptoms like gas and bloating linked to the probiotic component. Additionally, regulatory documents note rare instances of generalized gastrointestinal upset.

Q: What is the difference between Bactolac and the generic version?

A: Bactolac is officially designated as a dietary supplement, not a prescription drug. Unlike prescription drugs, governmental bodies do not approve or assign a generic name to specific supplement formulations before they are sold to the public.

Q: Is Bactolac safe for people over the age of 65?

A: Official guidance states that age-group administration must follow the age-specific rules and serving sizes printed on the product's label. Authoritative information regarding the effects of the Lactobacillus component in geriatric populations is often limited in descriptive findings.

Q: Does Bactolac affect birth control effectiveness?

A: The official documentation for Bactolac does not list specific interactions with oral contraceptives. General authoritative medical information suggests that the probiotic component is not known to affect the function of birth control pills.

Q: What happens if I miss a dose of Bactolac?

A: The necessary steps for handling a missed dose are governed by the instructions on the specific product's label. Adherence to the dosing and administration information provided by the manufacturer is necessary.

Q: What information is available about the long-term effects of Bactolac?

A: Research summaries for the probiotic component noted that studies had limited follow-up durations. Consequently, there is limited information available for long-term outcomes related to sustained changes in the gut microflora.

Q: What is the official classification of Bactolac?

A: The product is officially designated as a dietary supplement. This classification means that governmental agencies, such as the FDA, do not pre-approve the product for effectiveness or safety before it is made available to the public.

Q: Do studies suggest Bactolac's effectiveness changes over time?

A: Studies of the probiotic component focused on short-term outcomes and had limited follow-up durations. This means there is limited research-based information available regarding whether the product's effectiveness changes over long periods of time.

Q: Can Bactolac pass into breast milk?

A: The Folic Acid component of Bactolac is documented to pass into breast milk. Official guidance related to the Lactobacillus component describes the importance of weighing potential benefits against risks when considering use during breastfeeding.

Q: Is there any official guidance on stopping the use of Bactolac?

A: The appropriate time or procedure for stopping use is defined by the Suggested Use on the product's label. The manufacturer's label instructions must be followed precisely regarding the duration and procedure of use.

Q: Is Bactolac a treatment or a cure for the condition it addresses?

A: Products designated as dietary supplements are generally not approved by the FDA to diagnose, treat, cure, or prevent any disease. Official documentation focuses on the product's components and their associated research evidence.

Q: Does Bactolac interact with common vitamins like Vitamin D or C?

A: The official interaction documentation does not list specific common vitamins like D or C. However, the Folic Acid component is primarily associated with obscuring the diagnosis of Vitamin B12 deficiency at high doses.

Q: Do official documents mention Bactolac causing fatigue?

A: The official safety constraints highlight the Folic Acid component's potential to obscure the diagnosis of Vitamin B12 deficiency. This is a concern because the symptoms of Vitamin B12 deficiency can include weakness and fatigue.

Q: Are there different eligibility rules for children versus adults using Bactolac?

A: Eligibility and administration for specific age groups are governed solely by the age-specific rules and serving sizes printed on the product’s label, as defined by the manufacturer.

How should Bactolac be stored and disposed of?

How to Store and Dispose of Bactolac

Bactolac (Folic Acid and Lactobacillus species) must be stored at room temperature, generally between 15 C and 30 C (59 F and 86 F). It is essential to keep the product from freezing to preserve the viability of the probiotic components. The container must be kept tightly closed in the original packaging and stored in a dry place protected from light.


Handling and Disposal

This product must be stored out of the sight and reach of children and pets. For disposal of unused or expired Bactolac, follow official guidance by utilizing a drug take-back program. If this option is unavailable, the product should be mixed with an undesirable substance, sealed in a bag, and placed in the household trash. Do not flush the product down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bactolac found in:

A-Z Index: